Parallel Advisors, LLC

Position in RLAY — Relay Therapeutics, Inc.

CIK 1690010 SAN FRANCISCO, CA

Position in RLAY

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$23,443

+$11,135 QoQ

Shares Held

1,253

+1.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#222

of 256 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. RLAY ranks #62 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CORT	Corcept Therapeutics Inc	3,962,177	$344,511,290
2	VRTX	Vertex Pharmaceuticals Inc / Ma	5,389	$2,676,877
3	RCUS	Arcus Biosciences, Inc.	86,557	$2,668,552
4	REGN	Regeneron Pharmaceuticals, Inc.	1,063	$662,823
5	KRYS	Krystal Biotech, Inc.	1,699	$631,467
6	ARGX	Argenx SE	640	$593,772
7	INCY	Incyte Corp	4,961	$562,378
8	VKTX	Viking Therapeutics, Inc.	13,833	$539,625

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,443	1,253	+1.3%	Shares	Sole	2026-08-05
2026-03-31	$12,308	1,237	+4.0%	Shares	Sole	2026-05-07
2025-12-31	$10,058	1,189	+1.3%	Shares	Sole	2026-02-11
2025-09-30	$6,128	1,174	0.0%	Shares	Sole	2025-11-13
2025-06-30	$4,062	1,174	+1486.5%	Shares	Sole	2025-07-08
2025-03-31	$193	74	+428.6%	Shares	Sole	2025-04-08
2024-06-30	$91	14	0.0%	Shares	Sole	2024-08-08
2024-03-31	$116	14	0.0%	Shares	Sole	2024-05-06
2023-12-31	$154	14	-85.3%	Shares	Sole	2024-02-12
2023-09-30	$798	95	0.0%	Shares	Sole	2024-05-20
2023-06-30	$1,193	95	+691.7%	Shares	Sole	2024-05-20
2022-12-31	$179	12	0.0%	Shares	Sole	2023-02-06
2022-09-30	$268	12	0.0%	Shares	Sole	2022-11-10
2022-06-30	$201	12	-83.1%	Shares	Sole	2022-08-01
2021-12-31	$2,180	71	—	Shares	Sole	2022-01-20
No filing history on record for this holder in this stock.